Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Procalcitonin Versus C-Reactive Protein for Guiding Antibiotic Therapy in Sepsis: A Randomized Trial*

Oliveira, Carolina F., Botoni, Fernando A., Oliveira, Clara R. A., Silva, Camila B., Pereira, Helena A., Serufo, José C., Nobre, Vandack · 2013 · Critical Care Medicine

Abstract

OBJECTIVE: We sought to evaluate whether procalcitonin was superior to C-reactive protein in guiding antibiotic therapy in intensive care patients with sepsis. DESIGN: Randomized open clinical trial. SETTING: Two university hospitals in Brazil. PATIENTS: Patients with severe sepsis or septic shock. INTERVENTIONS: Patients were randomized in two groups: the procalcitonin group and the C-reactive protein group. Antibiotic therapy was discontinued following a protocol based on serum levels of these markers, according to the allocation group. The procalcitonin group was considered superior if the duration of antibiotic therapy was at least 25% shorter than in the C-reactive protein group. For both groups, at least seven full-days of antibiotic therapy were ensured in patients with Sequential Organ Failure Assessment greater than 10 and/or bacteremia at inclusion, and patients with evident resolution of the infectious process had antibiotics stopped after 7 days, despite biomarkers levels. MEASUREMENTS AND MAIN RESULTS: Ninety-four patients were randomized: 49 patients to the procalcitonin group and 45 patients to the C-reactive protein group. The mean age was 59.8 (SD, 16.8) years. The median duration of antibiotic therapy for the first episode of infection was 7.0 (Q1-Q3, 6.0-8.5) days in the procalcitonin group and 6.0 (Q1-Q3, 5.0-7.0) days in the C-reactive protein group (p=0.13), with a hazard ratio of 1.206 (95% CI, 0.774-1.3; p=0.13). Overall, protocol overruling occurred in only 13 (13.8%) patients. Twenty-one patients died in each group (p=0.836). CONCLUSIONS: C-reactive protein was as useful as procalcitonin in reducing antibiotic use in a predominantly medical population of septic patients, causing no apparent harm.

Overview

Integrity signals

Registry

Crossref · 10.1097/ccm.0b013e31828e969f

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 38 references

Cited by

See all 215

Metadata

Authors
Oliveira, C. F., Botoni, F. A., Oliveira, C. R. A., Silva, C. B., Pereira, H. A., Serufo, J. C., & Nobre, V.
Affiliations
Universidade Federal de Minas Gerais (BR)
Venue
Critical Care Medicine
Published
2013-10
Volume
41
Issue
10
Pages
2336-2343
ISSN
0090-3493 (ISSN-L)
OpenAlex
W2079018559
Cited by
213
References
38
Citations by year
2026: 9 · 2025: 14 · 2024: 24 · 2023: 14 · 2022: 19 · 2021: 13 · 2020: 25 · 2019: 14 · 2018: 23 · 2017: 19 · 2016: 14 · 2015: 10 · 2014: 14 · 2013: 1
FWCI
9.49
Type
journal article
Language
en
Open access
closed
Locations
  • Critical Care Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
Universidade Federal de Minas Gerais
Topics
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
  • Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
  • Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
Keywords
procalcitonin, C-reactive protein, sepsis, septic shock, antibiotic stewardship, antibiotic duration, biomarkers, intensive care unit patients, bacteremia
MeSH terms
Aged, Anti-Bacterial Agents, Brazil, C-Reactive Protein, Calcitonin, Female, Hospitals, University, Humans, Intensive Care Units, Male, Middle Aged, Protein Precursors, Shock, Septic, Biomarkers, Calcitonin Gene-Related Peptide, Confidence Intervals, Outcome Assessment, Health Care

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Procalcitonin Versus C-Reactive Protein for Guiding Antibiotic Therapy in Sepsis: A Randomized Trial*. https://app.cochat.ai/papers/10.1097/ccm.0b013e31828e969f
The paper
Oliveira, C. F., Botoni, F. A., Oliveira, C. R. A., Silva, C. B., Pereira, H. A., Serufo, J. C., & Nobre, V. (2013). Procalcitonin Versus C-Reactive Protein for Guiding Antibiotic Therapy in Sepsis: A Randomized Trial*. Critical Care Medicine. https://doi.org/10.1097/ccm.0b013e31828e969f

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.